Engage Psychosocial Intervention for Cancer Symptoms
190
about 3.5 years
18+
1 site in NC
What this study is about
This trial is testing a new psychosocial symptom management intervention called ENGAGE for people with advanced breast, prostate, lung, or colorectal cancer. Participants will be randomly assigned to receive ENGAGE or standard supportive care. Patient-reported outcomes will be measured at the beginning of the trial, after 2 months, and after 4 months.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in ENGAGE
- 2.Participate in Supportive Care
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: MD Anderson Symptom Inventory (MDASI) Interference with Daily Living Scale
Secondary: Brief Fatigue Inventory (BFI), Brief Pain Inventory (BPI), MD Anderson Symptom Inventory (MDASI) Interference with Daily Living Scale, MD Anderson Symptom Inventory (MDASI) Symptom Severity Scale, Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety-Short Form, Patient-Reported Outcomes Measurement Information System (PROMIS) Depression-Short Form, Patient-Reported Outcomes Measurement Information System (PROMIS) Self-Efficacy for Managing Symptoms
Gastroenterology, Oncology